Ulesfia is a benzyl alcohol pediculicide lotion that was recently approved by the FDA for the topical treatment of head lice. Ulesfia represents the first occlusive-based therapy that can be used for head lice approved by the regulator. The lotion is effective for treatment of head lice in adults and children six months of age and older.
Sciele Pharma, Inc., a Shionogi Company, had announced the availability of Ulesfia as the first and only prescription medication that helps kill head lice without any potential neurotoxic side effects.
Pediculus capitis or the scientific name for head lice is a concern affecting the health and hygiene of many children globally. Number of advantages are tied up with using benzyl alcohol solution. Some of the unique features of the lotion are the avoidance of pesticide use or neurotoxins, and complete the lack of resistance by lice as these are instantly killed by the effect of the lotion.
Benzyl alcohol lotion will kill lice but not the eggs, so the lotion must be used a second time seven days after the initial applications to kill the lice that may come out from these eggs.
There are many studies conducted in the market which track the development and market dynamics in global and Chinese benzyl alcohol industry. Recently, Prof Research Reports has added a report titled â€œMarket Research Report on Global and Chinese Benzyl Alcohol Industry, 2009-2019â€. The report offers an in-depth analysis of key market drivers, market dynamics, detailed market segmentation and provides an insight into the business profile of the key manufacturers, along with market forecast of the benzyl alcohol industry.
Approval of Ulesfia was based on a number of phase II and III clinical trials available in a formulary dossier from the manufacturer. The product is useful in cases where parents are concerned about the use of pediculicides, benzyl alcohol solution can be better alternative.